Assessment of the Effect of Spa Treatment on the Functional Severity of Arthrosis
VALS
Evolution of Clinical State of Patients With Rheumatic Disease on Lower Limbs or Rachis, 6 Months After Spa Treatment
1 other identifier
interventional
120
1 country
1
Brief Summary
Assessment of the effect of spa treatment on the functional severity of arthrosis. Official title: Evolution of clinical state of patients with rheumatic disease on lower limbs or rachis, 6 months after spa treatment. Primary outcome measure:
- Measuring the effect of spa treatment on functional severity of arthrosis
- Proportion of patients with a WOMAC score augmented by 9 or more, 6 months after enrollment (minimal clinically important difference) Secondary outcome measures
- Quantitative evaluation of pain
- Comparison of mean Visual Analogue Scale (VAS) pain scale between enrollment and 6 months after
- Quantitative evaluation of WOMAC
- Comparison of mean WOMAC between enrollment and 6 months after
- Impact of spa treatment on the patient's metabolism
- Height and Weight (BMI calculation)
- Blood pressure
- Heart rate
- Quality of life
- 36-Item Short Form (SF36) at enrollment, 3 months and 6 months
- EuroQol 5 Dimensions (EQ5D) questionnaire at enrollment, 3 months and 6 months
- Opinion of doctor and patient
- Semi-quantitative scale collected at enrollment, 3 months and 6 months
- Treatment follow-up
- Self-evaluation of pain
- Self-evaluation of pain with VAS pain scale every 6 week
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 29, 2016
CompletedFirst Submitted
Initial submission to the registry
April 24, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 13, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 13, 2017
CompletedFirst Posted
Study publicly available on registry
November 8, 2017
CompletedNovember 8, 2017
November 1, 2017
1.2 years
April 24, 2017
November 7, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Measuring the effect of spa treatment on functional severity of arthrosis
Proportion of patients with a WOMAC score augmented by 9 or more, at 6 months compared to baseline (minimal clinically important difference)
6 months
Secondary Outcomes (11)
Quantitative evaluation of pain
at baseline, 3 and 6 months
Quantitative evaluation of WOMAC
at baseline, 3 and 6 months
Patient's BMI
at baseline, 3 and 6 months
Quality of life
at baseline, 3 and 6 months
Quality of life
at baseline, 3 and 6 months
- +6 more secondary outcomes
Study Arms (1)
Spa Treatment
EXPERIMENTALBicarbonate and sulfurated water cares in Vals-les-Bains thermal cure center, massage, cataplasm.
Interventions
* Bath with immersion shower * Overall shower, penetrating shower * Multiple local application cataplasm * Single local application cataplasm * Inhalation or collective steam bath * Individual physiotherapy technique
Eligibility Criteria
You may qualify if:
- Patient with arthrosis or other rheumatic disease, located on the lower limbs or the rachis
- Rheumatic indication for spa treatment
- Diminution of mobility
- Affiliation to the French social security system or equivalent
- Available for a 6-months follow-up and an 18-days spa treatment
You may not qualify if:
- Pregnancy, parturient or breast feeding
- Psychiatric illness or social situation that would preclude study compliance
- Contraindication to spa treatment
- Predictable intolerance to thermal treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Thermes de Vals Les Bains
Vals-les-Bains, Ardèche, 07600, France
Related Publications (14)
Buskila D, Abu-Shakra M, Neumann L, Odes L, Shneider E, Flusser D, Sukenik S. Balneotherapy for fibromyalgia at the Dead Sea. Rheumatol Int. 2001 Apr;20(3):105-8. doi: 10.1007/s002960000085.
PMID: 11354556BACKGROUNDConstant F, Collin JF, Guillemin F, Boulange M. Effectiveness of spa therapy in chronic low back pain: a randomized clinical trial. J Rheumatol. 1995 Jul;22(7):1315-20.
PMID: 7562765BACKGROUNDElkayam O, Ophir J, Brener S, Paran D, Wigler I, Efron D, Even-Paz Z, Politi Y, Yaron M. Immediate and delayed effects of treatment at the Dead Sea in patients with psoriatic arthritis. Rheumatol Int. 2000;19(3):77-82. doi: 10.1007/s002960050107.
PMID: 10776684BACKGROUNDFranke A, Reiner L, Pratzel HG, Franke T, Resch KL. Long-term efficacy of radon spa therapy in rheumatoid arthritis--a randomized, sham-controlled study and follow-up. Rheumatology (Oxford). 2000 Aug;39(8):894-902. doi: 10.1093/rheumatology/39.8.894.
PMID: 10952746BACKGROUNDHuskisson EC. Measurement of pain. Lancet. 1974 Nov 9;2(7889):1127-31. doi: 10.1016/s0140-6736(74)90884-8. No abstract available.
PMID: 4139420BACKGROUNDKonrad K, Tatrai T, Hunka A, Vereckei E, Korondi I. Controlled trial of balneotherapy in treatment of low back pain. Ann Rheum Dis. 1992 Jun;51(6):820-2. doi: 10.1136/ard.51.6.820.
PMID: 1535495BACKGROUNDLeplege A, Ecosse E, Verdier A, Perneger TV. The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol. 1998 Nov;51(11):1013-23. doi: 10.1016/s0895-4356(98)00093-6.
PMID: 9817119BACKGROUNDNeumann L, Sukenik S, Bolotin A, Abu-Shakra M, Amir M, Flusser D, Buskila D. The effect of balneotherapy at the Dead Sea on the quality of life of patients with fibromyalgia syndrome. Clin Rheumatol. 2001;20(1):15-9. doi: 10.1007/s100670170097.
PMID: 11254234BACKGROUNDTubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N, Bombardier C, Felson D, Hochberg M, van der Heijde D, Dougados M. Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann Rheum Dis. 2005 Jan;64(1):34-7. doi: 10.1136/ard.2004.023028. Epub 2004 May 6.
PMID: 15130902BACKGROUNDvan Tubergen A, Landewe R, van der Heijde D, Hidding A, Wolter N, Asscher M, Falkenbach A, Genth E, The HG, van der Linden S. Combined spa-exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trial. Arthritis Rheum. 2001 Oct;45(5):430-8. doi: 10.1002/1529-0131(200110)45:53.0.co;2-f.
PMID: 11642642BACKGROUNDVan Tubergen A, Boonen A, Landewe R, Rutten-Van Molken M, Van Der Heijde D, Hidding A, Van Der Linden S. Cost effectiveness of combined spa-exercise therapy in ankylosing spondylitis: a randomized controlled trial. Arthritis Rheum. 2002 Oct 15;47(5):459-67. doi: 10.1002/art.10658.
PMID: 12382292BACKGROUNDVerhagen AP, de Vet HC, de Bie RA, Kessels AG, Boers M, Knipschild PG. Balneotherapy for rheumatoid arthritis and osteoarthritis. Cochrane Database Syst Rev. 2000;(2):CD000518. doi: 10.1002/14651858.CD000518.
PMID: 10796385BACKGROUNDWare JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473-83.
PMID: 1593914BACKGROUNDForestier R, Desfour H, Tessier JM, Francon A, Foote AM, Genty C, Rolland C, Roques CF, Bosson JL. Spa therapy in the treatment of knee osteoarthritis: a large randomised multicentre trial. Ann Rheum Dis. 2010 Apr;69(4):660-5. doi: 10.1136/ard.2009.113209. Epub 2009 Sep 3.
PMID: 19734131BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ludovic BACONNIER
Ardèche Méridionale Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 24, 2017
First Posted
November 8, 2017
Study Start
March 29, 2016
Primary Completion
June 13, 2017
Study Completion
June 13, 2017
Last Updated
November 8, 2017
Record last verified: 2017-11
Data Sharing
- IPD Sharing
- Will not share